SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications

ISSN
1664-3224
Date Issued
2022
Author(s)
Schlör, Anja
Hirschberg, Stefan
Amor, Ghada Ben
Meister, Toni Luise
Arora, Prerna
Hoffmann, Markus
Pfaender, Stephanie
Eddin, Omar Kamal
Kamhieh-Milz, Julian
Hanack, Katja
DOI
10.3389/fimmu.2022.930975
Abstract
The ongoing COVID-19 pandemic situation caused by SARS-CoV-2 and variants of concern such as B.1.617.2 (Delta) and recently, B.1.1.529 (Omicron) is posing multiple challenges to humanity. The rapid evolution of the virus requires adaptation of diagnostic and therapeutic applications.